Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2022 | 1 |
2023 | 2 |
2024 | 0 |
Search Results
3 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Efficacy and Safety of Sofosbuvir/Velpatasvir Plus Ribavirin in Patients with Hepatitis C Virus-Related Decompensated Cirrhosis.
Viruses. 2023 Sep 29;15(10):2026. doi: 10.3390/v15102026.
Viruses. 2023.
PMID: 37896803
Free PMC article.
Sofosbuvir and risk of estimated glomerular filtration rate decline or end-stage renal disease in patients with renal impairment.
Sulkowski M, Telep LE, Colombo M, Durand F, Reddy KR, Lawitz E, Bourlière M, Cheinquer N, Scherbakovsky S, Ni L, Force L, Ramroth H, Gaggar A, Chokkalingam AP, Sise ME.
Sulkowski M, et al. Among authors: scherbakovsky s.
Aliment Pharmacol Ther. 2022 May;55(9):1169-1178. doi: 10.1111/apt.16830. Epub 2022 Mar 2.
Aliment Pharmacol Ther. 2022.
PMID: 35235245
Free PMC article.
Clinical Trial.
Item in Clipboard
The tolerability of sofosbuvir/velpatasvir for 12 weeks in patients treated in the ASTRAL 1, 2 and 3 studies: A pooled safety analysis.
Jacobson IM, Bourgeois S, Mathurin P, Thuluvath P, Ryder SD, Gerken G, Hernandez C, Vanstraelen K, Scherbakovsky S, Osinusi A, Tedesco D, Foster GR.
Jacobson IM, et al. Among authors: scherbakovsky s.
J Viral Hepat. 2023 May;30(5):448-454. doi: 10.1111/jvh.13814. Epub 2023 Mar 2.
J Viral Hepat. 2023.
PMID: 36740893
Clinical Trial.
Item in Clipboard
Cite
Cite